Bayer has filed a lawsuit against Johnson & Johnson and Janssen Biotech, alleging the companies made false and misleading claims about the efficacy of its prostate cancer drug Nubeqa compared to the ...
In the real-world, Pluvicto™ showed 13.5 months median PFS in chemo-naïve patients with PSMA-positive mCRPC; Real‑world evidence showed Pluvicto achieved longer PFS when init ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results